免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

NCT:NCT06310031 · RECRUITING

NCT IDNCT06310031
狀態RECRUITING
開始日期2024-10-28
SponsorBrioHealth Solutions, Inc. (INDUSTRY)
First posted
Last updated

簡要摘要

The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑